the invention relates to a stable aqueous pharmaceutical formulations comprising a pdl1 antibodies. the invention relates to methods of making and methods of using such formulations and similar formulations.L'invention concerne des formulations pharmaceutiques aqueuses stables comprenant un anticorps anti-pdl1. L'invention concerne en outre des méthodes d'élaboration de telles formulations et des méthodes d'utilisation de telles formulations.
